Novo Nordisk, Valo Expand Cardiometabolic Drug Collaboration
This is a U.S. news story, published by Yahoo, that relates primarily to Novo Nordisk news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsNovo Nordisk news
For more Novo Nordisk news, you can click here:
more Novo Nordisk newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity drug market. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Last month Novo news, blockbuster obesity drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Danish drugmaker Novo NordiskReuters
•Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs
78% Informative
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence.
Analysts estimate the obesity drug market would be worth $150 billion in the next decade .
VR Score
89
Informative language
98
Neutral language
17
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links